the aid library

LIST OPTIONS

Filter

2644

Sort by:

Direction:

Download (97)

View PDF (924)

Subtyping social anxiety disorder in developed and developing countries

tein, D. J.et al. (2010) C2

DEPRESSION AND ANXIETY 27 : 390–403 (2010

Download (271)

View PDF (615)

Rohingya Refugee Crisis in Cox’s Bazar District, Bangladesh: Health Sector Bulletin No. 15, Reporting period: April to June 2021

World Health Organization (WHO) (2021) C_WHO

Download (122)

View PDF (833)

Philippine Action Plan to Combat AMR: One Health Approach

Phillipine Department of Health (2019) C_WHO

Antibiotics have been useful in fighting infectious diseases in our country for decades, but because of the overuse and misuse of these agents, an increasing number of organisms are now resistant to them. The Philippines, like other Southeast Asian countries, has already been encountering the many c... more

Download (121)

View PDF (144)

Broader health impacts of vertical responses to COVID-19 in low- and middle-income countries

Tabitha Hrynick, T.; S. Ripoll and S. Carter Social Science in Humanitarian Action (2021) C1

This paper reviews the effects of vertical responses to COVID-19 on health systems, services, and people’s access to and use of them in LMICs, where historic and ongoing under-investments heighten vulnerability to a multiplicity of health threats. We use the term ‘vertical response’ to describ... more

Download (152)

View PDF (203)

WHO strategic action and resource requirements to end the acute phase of the COVID-19 pandemic 2021

World Health Organization WHO (2021) C_WHO

WHO has a unique combination of technical public health and scientific expertise, and a global operational footprint, with field offices in more than 150 countries. In 2020, this global, technical, and operational reach meant WHO was able to support countries around the world in every aspect of COVI... more

Download (243)

View PDF (275)

Updated Recommendations Onservice Delivery For The Treatment And Care Of People Living With HIV. Summary Slides
recommended

World Health Organization WHO (2021) C_WHO

These guidelines provide new and updated recommendations on the use of point-of-care testing in children under 18 months of age and point-of-care tests to monitor treatment in people living with HIV; the treatment monitoring algorithm; and timing of antiretroviral therapy (ART) among people living w... more

Download (72)

View PDF (736)

WCO Syria Bi-Weekly Situation Report
recommended

World Health Organization WHO; Eastern Mediterranean Region (2021) C_WHO

Download (314)

View PDF (240)

African Antibiotic Treatment Guidelines for Common Bacterial Infections and Syndromes – Recommended Antibiotic Treatments in Neonatal and Pediatric Patients

Africa Centres for Disease Control and Prevention Center for Disease Dynamics, Economics & Policy (2021) CC

Download (278)

View PDF (270)

African Antibiotic Treatment Guidelines for Common Bacterial Infections and Syndromes – Recommended Antibiotic Treatments in Adult Patients
recommended

Africa Centres for Disease Control and Prevention Center for Disease Dynamics, Economics & Policy Africa Centres for Disease Control and Prevention Center for Disease Dynamics, Economics & Policy (2021) CC

Download (125)

View PDF (187)

Operational public health considerations for the prevention and control of infectious diseases in the context of Russia’s aggression towards Ukraine
recommended

European Centre for Disease Prevention and Control ECDC; WHO Europe (2022) C1

8 March 2022 A very large number of people from Ukraine are fleeing the country and entering the European Union (EU) countries bordering Ukraine (Hungary, Poland, Romania, Slovakia) and the EU-neighbourhood country of the Republic of Moldova. Those fleeing Ukraine - mainly women and children - are ... more

Download (117)

View PDF (132)

Health Care in Ukraine

Orange Health Consultants (2022) C2

The health sector In Ukraine is beginning to change in recent years. The sector, based on a system of health care (Semashko) originating from the Soviet Union, had been stagnant for many years. Remarkably little had changed since Independence and the health care system is as of today still character... more

Download (119)

View PDF (135)

ACT-Accelerator Transition Plan (1 Oct 2022 to 31 Mar 2023)

World Health Organization WHO (2022) C_WHO

31 Oct 2022 his plan outlines how the ACT-Accelerator will support countries as the world transitions to long-term COVID-19 control.   Recognizing the evolving nature of the COVID-19 virus and pandemic, the plan outlines changes to ACT-A’s set-up and ways of working, to ensure countries co... more

Download (76)

View PDF (350)

Research priorities for Chagas disease, human African trypanosomiasis and leishmaniasis

World Health Organization WHO (2012) C_WHO

This report provides a review and analysis of the research landscape for three diseases – Chagas disease, human African trypanosomiasis and leishmaniasis – that disproportionately afflict poor and remote populations with limited access to health services. It represents the work of the disease re... more

Download (114)

View PDF (153)

Efficacy and Safety of Pafuramidine versus Pentamidine Maleate for Treatment of First Stage Sleeping Sickness in a Randomized, Comparator-Controlled, International Phase 3 Clinical Trial

Pohlig G, Bernhard SC, Blum J, Burri C, Mpanya A, et al. PLOS Neclected Tropical Diseases (2016) CC

This was a Phase 3, multi-center, randomized, open-label, parallel-group, active control study where 273 male and female patients with first stage Trypanosoma brucei gambiense HAT were treated at six sites: one trypanosomiasis reference center in Angola, one hospital in South Sudan, and four hospita... more

Download (92)

View PDF (481)

Melarsoprol Resistance in African Trypanosomiasis

Fairlamb, A.H.; Horn, D. Elsevier Ltd. (2018) CC

Arsenical monotherapies were previously very successful for treating human African trypanosomiasis (HAT). Melarsoprol resistance emerged as early as the 1970s and was widespread by the late 1990s. Melarsoprol resistance represents the only example of widespread drug resistance in HAT patients wher... more

Download (100)

View PDF (115)

Annual Report of the WHO Country Office in Zimbabwe, 2022

World Health Organisation (WHO) (2023) C_WHO

This report highlights the work of the World Health Organization (WHO) in Zimbabwe towards contributing to the triple billion targets in the context of the Sustainable Development Goals (SDGs

Download (111)

View PDF (99)

WHO Ethiopia Annual Report 2022

World Health Organisation (WHO) (2023) C_WHO

Ethiopia is Africa’s second most populous country; with a population of 102 million and a growth rate of 2.6% in 2020, it is also the world’s 12th most populous one. The country is home to various ethnicities, with more than 80 different spoken languages. The country borders six countries. Most ... more

Download (84)

View PDF (89)

Draft Proposed programme budget 2022–2023: Building forward better

World Health Organization (WHO) World Health Organization (WHO) (2021) CC

The development of this draft Proposed programme budget 2022–2023 comes at a unique moment for WHO. The world is in the grip of the coronavirus disease (COVID-19) pandemic and faces health, social and economic consequences on an unprecedented scale. Although it is not known when the COVID-19 pande... more

Download (22)

View PDF (17)

Non-communicable diseases, injuries, and mental ill-health in Africa: the role of the Africa CDC 2023

Mohammed A. , Putnis N. et al. The Lancet Global Health (2023) CC2

The article "Non-communicable diseases, injuries, and mental ill-health in Africa: the role of the Africa Centres for Disease Control and Prevention" examines the role of the Africa CDC in addressing non-communicable diseases (NCDs), injuries, and mental health across the continent. It highlights ho... more

Download (7)

View PDF (6)

Mpox Testing Strategy - November 2024

Africa Center for Disease Control and Prevention (2024) CC

Mpox is an emerging zoonotic disease caused by the mpox virus, a member of the Orthopoxvirus genus closely related to the variola virus that causes smallpox. Mpox was first discovered in 1958 when outbreaks of a pox-like disease occurred in monkeys kept for research. The first human case was recorde...d in 1970 in the Democratic Republic of the Congo (DRC) during a period of intensified effort to eliminate smallpox and since then the infection has been reported in a number of African countries. Mpox can spread in humans through close contact, usually skin-to-skin contact, including sexual contact, with an infected person or animal, as well as with materials contaminated with the virus such as clothing, beddings and towels, and respiratory droplets in prolonged face to face contact. People remain infectious from the onset of symptoms until all the lesions have scabbed and healed. The virus may spread from infected animals through handling infected meat or through bites or scratches. Diagnosis is confirmed by polymerase chain reaction (PCR) testing of material from a lesion for the virus’s DNA. Two separate clades of the mpox virus are currently circulating in Africa: Clade I, which includes subclades Ia and Ib, and Clade II, comprising subclades IIa and IIb. Clade Ia and Clade Ib have been associated with ongoing human-to-human transmission and are presently responsible for outbreaks in the Democratic Republic of the Congo (DRC), while Clade Ib is also contributing to outbreaks in Burundi and other countries. In 2022‒2023 mpox caused a global outbreak in over 110 countries, most of which had no previous history of the disease, primarily driven by human-to-human transmission of clade II through sexual contact. In just over a year, over 90,000 cases and 150 deaths were reported to the WHO. For the second time since 2022, mpox has been declared a global health emergency as the virus spreads rapidly across the African continent. On 13 Aug 2024, Africa CDC declared the ongoing mpox outbreak a Public Health Emergency of Continental Security (PHECS), marking the first such declaration by the agency since its inception in 2017.7 This declaration empowered the Africa CDC to lead and coordinate responses to the mpox outbreak across affected African countries. On August 14, 2024, the WHO declared the resurgence of mpox a Public Health Emergency of International Concern (PHEIC) emphasizing the need for coordinated international response. As of August 2024, Mpox has expanded beyond its traditional endemic regions, with new cases reported in countries including Sweden, Thailand, the Philippines, and Pakistan. Sweden has confirmed its first case of Clade 1 variant, which has been rapidly spreading in Africa, particularly in DRC. The emergence of this new variant raises concerns about its potential for higher lethality and transmission rates outside Africa. more

Updated Recommendations Onservice Delivery For The Treatment And Care Of People Living With HIV. Summary Slides recommended

WCO Syria Bi-Weekly Situation Report recommended

African Antibiotic Treatment Guidelines for Common Bacterial Infections and Syndromes – Recommended Antibiotic Treatments in Adult Patients recommended

Operational public health considerations for the prevention and control of infectious diseases in the context of Russia’s aggression towards Ukraine recommended

Updated Recommendations Onservice Delivery For The Treatment And Care Of People Living With HIV. Summary Slides
recommended

WCO Syria Bi-Weekly Situation Report
recommended

African Antibiotic Treatment Guidelines for Common Bacterial Infections and Syndromes – Recommended Antibiotic Treatments in Adult Patients
recommended

Operational public health considerations for the prevention and control of infectious diseases in the context of Russia’s aggression towards Ukraine
recommended